Back to search

Switzerland· 54159021

Edronax, Tabletten 4 mg

A reboxetine product containing reboxetinum, registered in Switzerland by Pfizer AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC N06AX18

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedEdronax, Tabletten 4 mgATCN06AX18REGISTER NO.54159021PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Reboxetine is registered in 8 of 19 countries.

Countries holding a registration under ATC N06AX18 (reboxetine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 5 of them publish a price we can compare per daily dose

Reboxetine · ATC N06AX18

8 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of reboxetine costs, country by country.

Normalised to the WHO defined daily dose (8 mg), the median price runs from $1.04 in Italy to $2.27 in Switzerland — a ×2.2 gap.

  • Switzerland: $2.27 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Reboxetine · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.27
  • IT Italy$1.04
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
reboxetinum
Manufacturer
Pfizer AG
Country
Switzerland (CH)
ATC code
N06AX18
ATC class
Reboxetine
Defined daily dose
8 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680541590210
    100 Stk
    CHF 72.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for reboxetine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Reboxetine · interactions on record

19 records

19 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Reboxetine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All reboxetine products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Edronax
  • Belgium · Edronax
  • Bulgaria · Едронакс
  • Germany · Edronax
  • Spain · Irenor, Norebox
  • United Kingdom (Northern Ireland) · Edronax
  • Croatia · Edronax
  • Ireland · Edronax
  • Italy · Edronax
  • Luxembourg · Edronax
  • Poland · Edronax
  • Portugal · Edronax
  • Sweden · Edronax
  • Slovenia · Edronax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a5efb1c7-ac88-460b-a4a7-b22f0f6b2082
GET /v1/drugs/a5efb1c7-ac88-460b-a4a7-b22f0f6b2082?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "reboxetinum 4 mg",
  "valid_from": "2001-07-01",
  "limitations": null,
  "galenic_form": "Tabl 4 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2001-07-01",
  "self_retention_pct": 10
}

See everything about reboxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.